Pub. Date : 2017 Feb
PMID : 27986714
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Data from the BELLE-3 trial suggest that adding the investigational PI3K inhibitor buparlisib to endocrine therapy may improve outcomes for patients with hormone receptor-positive advanced breast cancer whose tumors become resistant to mTOR inhibition. | NVP-BKM120 | mechanistic target of rapamycin kinase | Homo sapiens |